Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
By A. Templeton, M. McNamara, Bostjan Seruga, F. Vera-Badillo, P. Aneja, A. Ocaña, R. Leibowitz-Amit, G. Sonpavde, Jennifer J. Knox, B. Tran and 2 more. Journal of the National Cancer Institute, 2014
3,049 citations recorded by the source corpus.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/227aff7dbb9d7c96732f8f6939a00b0bc697de14
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? (2018, background): “In general, the blood NLR is high in patients with more advanced or aggressive cancers (Guthrie et al., 2013), and correlates with poor survival of patients with many solid tumors (Paramanathan et al., 2014; Templeton et al., 2014).”
- Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis (2017, methodology): “Discussion High NLR is associated with poor survival in patients diagnosed with several types of cancer [4].”
- Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases (2022, background): “[58], in their metanalysis, demonstrated that NLR higher than 4 independently predicts a shorter overall survival with many tumors (HR 1.”